OTHER · Unmapped registry intervention
data collection
Find medicine records ·
Find other trials using this name
Clinical trial
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
NCT02622581
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedClinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Non-small Cell Lung Cancer Metastaticunresolved
Non-small Cell Lung Cancer Stage IIunresolved
Non Small Cell Lung Cancer Stage IIIunresolved
Small-cell Lung Cancerunresolved
Non-small Cell Lung Cancer Stage Iunresolved
Interventions
data collectionOTHER
Sponsors & collaborators
AIO-Studien-gGmbHlead sponsor
AstraZenecacollaborator
Celgene Corporationcollaborator
Merck Sharp & Dohme LLCcollaborator
Novartis Pharmaceuticalscollaborator
Pfizercollaborator
Boehringer Ingelheimcollaborator
Bristol-Myers Squibbcollaborator
iOMEDICO AGcollaborator
Eli Lilly and Companycollaborator
Roche Pharma AGcollaborator
Takedacollaborator
Amgencollaborator
Janssen-Cilag G.m.b.Hcollaborator
GlaxoSmithKlinecollaborator
Daiichi Sankyocollaborator
Regeneron Pharmaceuticalscollaborator
Gilead Sciencescollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02622581 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.